The AdC (Portuguese Competition Authority) and Infarmed - National Authority of Medicines and Health Products signed a memorandum of understanding (MoU) that establishes instruments for cooperation and exchange of information, thereby improving the effectiveness of both authorities in fulfilling their respective objectives.
The timely detection of market failures or competitive distortions is one of the purposes shared by AdC and Infarmed. The MoU establishes a regular exchange of information on the supervision and monitoring of the sale and consumption of medical products for human use, medical devices and cosmetics.
By allowing access to reliable information, the MoU will facilitate the detection of anti-competitive practices in the pharmaceutical sector.
Please read more bellow in the press release.